91296-17-2Relevant articles and documents
HETEROCYCLIC COMPOUND AND USE THEREOF
-
Paragraph 0633-0634, (2019/10/17)
The present invention provides a heterocyclic compound having an antagonistic action on an NMDA receptor containing the NR2B subunit, and expected to be useful as an agent for the prophylaxis or treatment of major depression, bipolar disorder, migraine, p
Cephem compounds
-
, (2008/06/13)
Cephem compounds of the following formula are disclosed: STR1 wherein R1 is amino or protected amino group. R2 is H or an organic group, R3 is H or an organic group, R4 is H, lower alkyl, carboxy, protected carb